Literature DB >> 10603385

Contribution of Escherichia coli alpha-hemolysin to bacterial virulence and to intraperitoneal alterations in peritonitis.

A K May1, T G Gleason, R G Sawyer, T L Pruett.   

Abstract

Alpha-hemolysin (Hly) is a common exotoxin produced by Escherichia coli that enhances virulence in a number of clinical infections. The addition of hemolysin production to laboratory bacterial strains is known to increase the lethality of E. coli peritonitis. However, the mechanisms involved have not been determined and the contribution of hemolysin to the alterations in the host intraperitoneal environment and the leukocyte response is not known. Utilizing a rat peritonitis model, we show that wild-type hemolytic E. coli strains have a significant competitive advantage over nonhemolytic strains within the peritoneum. To examine the specific contribution of Hly to E. coli-induced virulence and alterations within the peritoneum, a mixed peritonitis model of E. coli, Bacteroides fragilis, and sterile fecal adjuvant was used. Three transformed E. coli strains were utilized: one strongly secretes active hemolysin (WAF 270), a second secretes active hemolysin but a reduced amount (WAF 260), and the third does not produce hemolysin (WAF 108). After an equal inoculum of each of the three strains, WAF 270 produced a markedly increased lethality and an increased recovery of both E. coli and B. fragilis from the host relative to the other strains. Changes in the intraperitoneal pH, degree of erythrocyte lysis, and recruitment and viability of leukocytes within the peritoneum following the induction of peritonitis differed significantly between the strongly hemolytic and nonhemolytic strains. Induction of peritonitis with WAF 270 caused a pronounced decrease in intraperitoneal pH, lysis of most of the intraperitoneal erythrocytes, and a marked decrease in recoverable viable leukocytes compared to WAF 108. Thus, hemolysin production by E. coli within the peritoneum may alter not only the host's ability to control the hemolytic strain itself but also other organisms.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10603385      PMCID: PMC97118          DOI: 10.1128/IAI.68.1.176-183.2000

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  44 in total

1.  The bacteriology of intra-abdominal infections.

Authors:  B Lorber; R M Swenson
Journal:  Surg Clin North Am       Date:  1975-12       Impact factor: 2.741

2.  Quantitative study of the binding and hemolytic efficiency of Escherichia coli hemolysin.

Authors:  B Eberspächer; F Hugo; S Bhakdi
Journal:  Infect Immun       Date:  1989-03       Impact factor: 3.441

3.  The open abdomen. The Marlex mesh and zipper technique: a method of managing intraperitoneal infection.

Authors:  G L Walsh; P Chiasson; G Hedderich; M J Wexler; J L Meakins
Journal:  Surg Clin North Am       Date:  1988-02       Impact factor: 2.741

Review 4.  Escherichia coli alpha-hemolysin: characteristics and probable role in pathogenicity.

Authors:  S J Cavalieri; G A Bohach; I S Snyder
Journal:  Microbiol Rev       Date:  1984-12

5.  Mechanism of Escherichia coli alpha-hemolysin-induced injury to isolated renal tubular cells.

Authors:  W F Keane; R Welch; G Gekker; P K Peterson
Journal:  Am J Pathol       Date:  1987-02       Impact factor: 4.307

6.  Studies on the origin of the alpha-haemolysin produced by Escherichia coli.

Authors:  S E Jorgensen; E C Short; H J kurtz; H K Mussen; G K Wu
Journal:  J Med Microbiol       Date:  1976-05       Impact factor: 2.472

7.  Properties of strains of Escherichia coli isolated from the faeces of patients with ulcerative colitis, patients with acute diarrhoea and normal persons.

Authors:  E M Cooke
Journal:  J Pathol Bacteriol       Date:  1968-01

8.  Influence of pH and temperature on the luminol-dependent chemiluminescence of human polymorphonuclear leucocytes.

Authors:  J A Westman
Journal:  Scand J Clin Lab Invest       Date:  1986-09       Impact factor: 1.713

9.  Escherichia coli hemolysin may damage target cell membranes by generating transmembrane pores.

Authors:  S Bhakdi; N Mackman; J M Nicaud; I B Holland
Journal:  Infect Immun       Date:  1986-04       Impact factor: 3.441

10.  Role of Escherichia coli alpha-hemolysin and bacterial adherence in infection: requirement for release of inflammatory mediators from granulocytes and mast cells.

Authors:  B König; W König; J Scheffer; J Hacker; W Goebel
Journal:  Infect Immun       Date:  1986-12       Impact factor: 3.441

View more
  14 in total

1.  Loss of regulatory protein RfaH attenuates virulence of uropathogenic Escherichia coli.

Authors:  Gábor Nagy; Ulrich Dobrindt; György Schneider; A Salam Khan; Jörg Hacker; Levente Emödy
Journal:  Infect Immun       Date:  2002-08       Impact factor: 3.441

Review 2.  Role of pore-forming toxins in bacterial infectious diseases.

Authors:  Ferdinand C O Los; Tara M Randis; Raffi V Aroian; Adam J Ratner
Journal:  Microbiol Mol Biol Rev       Date:  2013-06       Impact factor: 11.056

3.  The UPEC pore-forming toxin α-hemolysin triggers proteolysis of host proteins to disrupt cell adhesion, inflammatory, and survival pathways.

Authors:  Bijaya K Dhakal; Matthew A Mulvey
Journal:  Cell Host Microbe       Date:  2012-01-19       Impact factor: 21.023

4.  Characteristics of Virulence Factors and Prevalence of Virulence Markers in Resistant Escherichia coli from Patients with Gut and Urinary Infections in Lafia, Nigeria.

Authors:  Olukayode Olugbenga Orole; Salihu Moses Gambo; Victor Stephen Fadayomi
Journal:  Microbiol Insights       Date:  2022-06-28

5.  Toxin production and antibiotic resistances in Escherichia coli isolated from bathing areas along the coastline of the Oslo fjord.

Authors:  Colin Charnock; Anne-Lise Nordlie; Bjarne Hjeltnes
Journal:  Curr Microbiol       Date:  2014-05-07       Impact factor: 2.188

6.  A uropathogenicity island contributes to the pathogenicity of Escherichia coli strains that cause neonatal meningitis.

Authors:  Véronique Houdouin; Stéphane Bonacorsi; Naima Brahimi; Olivier Clermont; Xavier Nassif; Edouard Bingen
Journal:  Infect Immun       Date:  2002-10       Impact factor: 3.441

7.  Perivascular macrophages mediate neutrophil recruitment during bacterial skin infection.

Authors:  Arby Abtin; Rohit Jain; Andrew J Mitchell; Ben Roediger; Anthony J Brzoska; Shweta Tikoo; Qiang Cheng; Lai Guan Ng; Lois L Cavanagh; Ulrich H von Andrian; Michael J Hickey; Neville Firth; Wolfgang Weninger
Journal:  Nat Immunol       Date:  2013-11-24       Impact factor: 25.606

8.  Interactions of Segmented Filamentous Bacteria (Candidatus Savagella) and bacterial drivers in colitis-associated colorectal cancer development.

Authors:  Annie E Wolfe; Jacob E Moskowitz; Craig L Franklin; Timothy L Wiemken; Aaron C Ericsson
Journal:  PLoS One       Date:  2020-07-24       Impact factor: 3.240

9.  Outer membrane vesicles derived from Escherichia coli up-regulate expression of endothelial cell adhesion molecules in vitro and in vivo.

Authors:  Ji Hyun Kim; Yae Jin Yoon; Jaewook Lee; Eun-Jeong Choi; Namwoo Yi; Kyong-Su Park; Jaesung Park; Jan Lötvall; Yoon-Keun Kim; Yong Song Gho
Journal:  PLoS One       Date:  2013-03-14       Impact factor: 3.240

10.  P2X receptor-dependent erythrocyte damage by α-hemolysin from Escherichia coli triggers phagocytosis by THP-1 cells.

Authors:  Steen K Fagerberg; Marianne Skals; Jens Leipziger; Helle A Praetorius
Journal:  Toxins (Basel)       Date:  2013-03-05       Impact factor: 4.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.